...
首页> 外文期刊>Free Radical Biology and Medicine: The Official Journal of the Oxygen Society >Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy.
【24h】

Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy.

机译:糖尿病心脏中金属硫蛋白对硝化损伤的抑制有助于预防心肌病。

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetic cardiomyopathy has become a major contributor to the increased mortality of diabetic patients. Although the development and progression of diabetic cardiomyopathy are considered to be associated with diabetes-derived oxidative stress, the precise mechanisms for and effectively preventive approaches to diabetic cardiomyopathy remain to be explored. Recent studies showed that reactive oxygen or nitrogen species (ROS/RNS) not only play a critical role in the initiation of diabetic cardiomyopathy, but also play an important role in physiological signaling. Therefore, this review will first discuss the dual roles of ROS/RNS in the physiological signaling and pathogenic remodeling leading to cardiomyopathy under diabetic conditions. The significant prevention of diabetic cardiomyopathy by metallothionein (MT) as a potent and nonspecific antioxidant will be also summarized. It is clearly revealed that although dual roles of peroxynitrite-nitrated proteins have been indicated under both physiological and pathogenic conditions, suppression of nitrative damage by MT in the diabetic heart is the major mechanism responsible for its prevention of diabetic cardiomyopathy. Finally the potential for clinical enhancement of the cardiac MT expression to prevent or delay the occurrence of cardiomyopathy in diabetic patients will also be addressed.
机译:糖尿病性心肌病已成为糖尿病患者死亡率增加的主要因素。尽管糖尿病性心肌病的发生和发展被认为与糖尿病引起的氧化应激有关,但仍需探索用于糖尿病性心肌病的确切机制和有效预防方法。最近的研究表明,活性氧或氮(ROS / RNS)不仅在糖尿病性心肌病的发作中起关键作用,而且在生理信号传导中也起重要作用。因此,本综述将首先讨论ROS / RNS在糖尿病条件下导致心肌病的生理信号传导和致病性重塑中的双重作用。金属硫蛋白(MT)作为一种有效的非特异性抗氧化剂,可以有效预防糖尿病性心肌病。清楚地表明,尽管在生理和致病条件下都表明过氧亚硝酸盐硝化的蛋白质具有双重作用,但是糖尿病心脏中MT抑制硝化损伤是其预防糖尿病性心肌病的主要机制。最后,还将探讨临床增强心脏MT表达以预防或延迟糖尿病患者心肌病发生的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号